-
1
-
-
33751515147
-
CD4+ count guided interruption of antiretroviral treatment
-
El-Sadr WM, Lundgren JD, Neaton JD, et al.: CD4+ count guided interruption of antiretroviral treatment. N Engl J Med 2006;355;2359-2361.
-
(2006)
N Engl J Med
, vol.355
, pp. 2359-2361
-
-
El-Sadr, W.M.1
Lundgren, J.D.2
Neaton, J.D.3
-
2
-
-
20144370827
-
Interruption of highly active antiretroviral therapy in HIV clinical practice
-
The Italian Cohort of Antiretroviral-Näve Patients Study Group
-
The Italian Cohort of Antiretroviral-Näve Patients Study Group: Interruption of highly active antiretroviral therapy in HIV clinical practice. J Acquir Immune Defic Syndr 2005; 38:407-416.
-
(2005)
J Acquir Immune Defic Syndr
, vol.38
, pp. 407-416
-
-
-
3
-
-
33746713760
-
Highly active antiretroviral therapy interruption: Predictors and virologic and immunologic consequences
-
The CASCADE Collaboration
-
The CASCADE Collaboration: Highly active antiretroviral therapy interruption: Predictors and virologic and immunologic consequences. J Acquir Immune Defic Syndr 2006; 42:554-561.
-
(2006)
J Acquir Immune Defic Syndr
, vol.42
, pp. 554-561
-
-
-
4
-
-
56549110656
-
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitorbased regimen
-
Fox Z, Phillips A, Cohen C, et al.: Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitorbased regimen. AIDS 2008;22:2279-2289.
-
(2008)
AIDS
, vol.22
, pp. 2279-2289
-
-
Fox, Z.1
Phillips, A.2
Cohen, C.3
-
5
-
-
58749091289
-
Two-months-off, fourmonths-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: A randomized trial involving West African adults
-
Danel C, Moh R, Chaix ML, et al.: Two-months-off, fourmonths- on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: A randomized trial involving West African adults. J Infect Dis 2009;199:66-76.
-
(2009)
J Infect Dis
, vol.199
, pp. 66-76
-
-
Danel, C.1
Moh, R.2
Chaix, M.L.3
-
6
-
-
34848865063
-
Determinants of virologic and immunologic outcomes in chronically HIVinfected subjects undergoing repeated treatment interruptions
-
The Istituto Superiore di Sanità -Pulsed Antiretroviral Therapy (ISS-PART) Study
-
Palmisano L, Giuliano M, Bucciardini R, et al.: Determinants of virologic and immunologic outcomes in chronically HIVinfected subjects undergoing repeated treatment interruptions; The Istituto Superiore di Sanità -Pulsed Antiretroviral Therapy (ISS-PART) Study. J Acquir Immune Defic 2007;46: 39-47.
-
(2007)
J Acquir Immune Defic
, vol.46
, pp. 39-47
-
-
Palmisano, L.1
Giuliano, M.2
Bucciardini, R.3
-
7
-
-
0003663974
-
-
CPMP/ICH/281/95. EEC Note for Guidance, London, UK
-
CPMP/ICH/281/95. EEC Note for Guidance, Validation of Analytical Procedures: Methodology. London, UK, 1996. http://www.emea.eu.int/htms/ human(ich/quality/ichfin .htm.
-
(1996)
Validation of Analytical Procedures: Methodology
-
-
-
8
-
-
0003484310
-
-
U.S. Department of Health and Human Services Food and Drug Administration. U.S. Department of Health and Human Services, Beltsville, MD
-
U.S. Department of Health and Human Services Food and Drug Administration: Guidance for Industry: Bioanalytical Method Validation. U.S. Department of Health and Human Services, Beltsville, MD, 2001.
-
(2001)
Guidance for Industry: Bioanalytical Method Validation
-
-
-
9
-
-
59049090776
-
Liquid chromatography-electrospray ionization mass spectrometry determination of methylphenidate and ritalinic acid in conventional and non-conventional biological matrices
-
Marchei E, Farré M, Pellegrini M, et al.: Liquid chromatography- electrospray ionization mass spectrometry determination of methylphenidate and ritalinic acid in conventional and non-conventional biological matrices. J Pharm Biomed Anal 2009;49:434-439.
-
(2009)
J Pharm Biomed Anal
, vol.49
, pp. 434-439
-
-
Marchei, E.1
Farré, M.2
Pellegrini, M.3
-
10
-
-
34547798122
-
Stopping antiretroviral therapy
-
Taylor S, Boffito M, Khoo S, Smit E, and Back D: Stopping antiretroviral therapy. AIDS 2007;21:1673-1682.
-
(2007)
AIDS
, vol.21
, pp. 1673-1682
-
-
Taylor, S.1
Boffito, M.2
Khoo, S.3
Smit, E.4
Back, D.5
-
11
-
-
31044456584
-
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation
-
An Adult AIDS Clinical Trials Group Study
-
Ribaudo HJ, Haas DW, Tierney C, et al.: Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: An Adult AIDS Clinical Trials Group Study. Clin Infect Dis 2006;42:401-407.
-
(2006)
Clin Infect Dis
, vol.42
, pp. 401-407
-
-
Ribaudo, H.J.1
Haas, D.W.2
Tierney, C.3
-
12
-
-
2942674438
-
Clinical implications of stopping nevirapine-based antiretroviral therapy: Relative pharmacokinetics and avoidance of drug resistance
-
Mackie NE, Fidler S, Tamm N, et al.: Clinical implications of stopping nevirapine-based antiretroviral therapy: Relative pharmacokinetics and avoidance of drug resistance. HIV Med 2004;5:180-184.
-
(2004)
HIV Med
, vol.5
, pp. 180-184
-
-
MacKie, N.E.1
Fidler, S.2
Tamm, N.3
-
13
-
-
43249121119
-
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children
-
Cressey TR, Green H, Khoo S, et al.: Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children. Clin Infect Dis 2008;46:1601-1608.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 1601-1608
-
-
Cressey, T.R.1
Green, H.2
Khoo, S.3
-
14
-
-
34147106431
-
Nevirapine clearance from plasma in African adults stopping therapy: A pharmacokinetic substudy
-
Kikaire B, Khoo S, Walker AS, et al.: Nevirapine clearance from plasma in African adults stopping therapy: A pharmacokinetic substudy. AIDS 2007;21:733-737.
-
(2007)
AIDS
, vol.21
, pp. 733-737
-
-
Kikaire, B.1
Khoo, S.2
Walker, A.S.3
-
15
-
-
47549090814
-
Detection of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy
-
Hare CB, Mellors J, Krambrink A, et al.: Detection of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy. Clin Infect Dis 2008;47:421-424.
-
(2008)
Clin Infect Dis
, vol.47
, pp. 421-424
-
-
Hare, C.B.1
Mellors, J.2
Krambrink, A.3
-
16
-
-
56749132030
-
Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption
-
Darwich L, Esteve A, Ruiz L, Bellido R, Clotet B, and Martinez-Picado J: Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption. Antivir Ther 2008;13:945-951.
-
(2008)
Antivir Ther
, vol.13
, pp. 945-951
-
-
Darwich, L.1
Esteve, A.2
Ruiz, L.3
Bellido, R.4
Clotet, B.5
Martinez-Picado, J.6
|